Publications by authors named "Mario Widel"

Claim this Profile
E
Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice.
Ruben Vidal, Leticia Miravalle, Xiaoying Gao, Ana G Barbeito, Martin A Baraibar, Mario Widel

J Neurosci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Robert J Heine, Luc F Van Gaal, Don Johns, Michael J Mihm, Mario H Widel

Ann Intern Med· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
Vinod Mattoo, David Eckland, Mario Widel, Santiago Duran, Carmen Fajardo

Clin Ther· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes.
Antonio Ceriello, Don Johns, Mario Widel, David J Eckland, Kathryn J Gilmore

Diabetes Care· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes.
Meng H Tan, N Bradly Glazer, Don Johns, Mario Widel, Kathryn J Gilmore

Curr Med Res Opin· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis